-
DISPARITY IMPLICATIONS OF MACHINE-LEARNING-BASED MTM ELIGIBILITY CRITERIA
Feb 25, 2026, 14:40 PM -
TRENDS IN DIABETIC KETOACIDOSIS INCIDENCE AMONG NEW USERS OF SGLT2 INHIBITORS FOLLOWING EXPANDED INDICATIONS, 2020-2023
Feb 25, 2026, 14:40 PM -
EVALUATING INDIVIDUAL-LEVEL ASSOCIATION BETWEEN RADIOGRAPHIC PROGRESSION-FREE SURVIVAL (PFS) AND OVERALL SURVIVAL (OS) IN METASTATIC-HORMONE SENSITIVE PROSTATE CANCER (MHSPC): AN INDIRECT ILLNESS-DEATH MODELING APPROACH
Feb 25, 2026, 14:40 PM -
COMPARATIVE EFFECTIVENESS ANALYSIS OF FOLFIRINOX AND GEMCITABINE PLUS NAB-PACLITAXEL IN METASTATIC PANCREATIC ADRENOCARCINOMA; USING MARGINAL STRUCTURAL MODEL
Feb 25, 2026, 14:40 PM -
WHAT CAN SOCIAL DRIVERS OF HEALTH DATA TELL US ABOUT HEALTH PLAN MEMBERS IN A LARGE REAL-WORLD DATABASE?
Feb 25, 2026, 14:40 PM -
REAL WORLD EVIDENCE FOR DOSE-RESPONSE RELATIONSHIP BETWEEN WEIGHT LOSS AND CLINICAL OUTCOMES IN OBESITY RELATED COMORBIDITIES
Feb 25, 2026, 14:40 PM -
GOAL INVENTORIES IN STANDARDIZED IMPLEMENTATION OF PERSONALIZED OUTCOME ASSESSMENTS USING GOAL ATTAINMENT SCALING: A LANDSCAPE ANALYSIS
Feb 25, 2026, 14:40 PM -
THE ROLE OF SAFETY AND TOLERABILITY IN HTA VALUE ASSESSMENT: EVIDENCE REQUIREMENTS AND IMPACT ACROSS KEY EUROPEAN MARKETS
Feb 25, 2026, 14:40 PM -
VALIDATION OF DIAGNOSES CODES FOR IDENTIFYING PATIENTS WITH HEPATITIS C VIRUS IN EHR IN A US, REAL-WORLD POPULATION
Feb 25, 2026, 14:40 PM -
TRENDS IN ATOPIC DERMATITIS MEDICATION UTILIZATION AND PHARMACY COSTS IN PEDIATRIC COMMERCIAL AND MEDICAID POPULATIONS
Feb 25, 2026, 14:40 PM -
EVALUATION OF OFF-THE-SHELF AGENT-BASED AI TOOL CLAUDE CODE FOR RAPID REPLICATION OF A PUBLISHED COST-EFFECTIVENESS MODEL
Feb 25, 2026, 14:40 PM -
EARLY TOXICITIES AND ECONOMIC BURDEN OF CAR-T THERAPY IN THE UNITED STATES: A RETROSPECTIVE COHORT STUDY OF ICANS AND CRS USING OPTUM DATA
Feb 25, 2026, 14:40 PM -
EXPLORING POTENTIAL INTERACTIONS BETWEEN STATINS AND COVID-19 MEDICATIONS
Feb 25, 2026, 14:40 PM -
?ECONOMIC IMPACT OF PET-18FLUTEMETAMOL GUIDED TREATMENT ALLOCATION IN THE DIAGNOSIS AND MANAGEMENT OF ALZHEIMER DISEASE. A BUDGET IMPACT MODEL FOR EUROPEAN PAYERS...
Feb 25, 2026, 14:40 PM -
MULTI-CRITERIA DECISION ANALYSIS IN HEALTH INTERVENTION PRIORITY SETTING FOR UNIVERSAL HEALTH COVERAGE IN KENYA: AN EXPLORATORY STUDY
Feb 25, 2026, 14:40 PM -
TRENDS IN PREVENTABLE HOSPITALIZATIONS BEFORE AND AFTER MEDICAID EXPANSION IN KENTUCKY
Feb 25, 2026, 14:40 PM -
BEYOND THE SINGLE QALY: CHALLENGES IN APPLYING NON-HALY OUTCOMES IN ECONOMIC EVALUATIONS
Feb 25, 2026, 14:40 PM -
100% WHEY PEPTIDE-BASED FORMULAS COMPARED TO POLYMERIC ENTERAL NUTRITION AMONG CHILDREN RECEIVING HOME ENTERAL NUTRITION: A COST-BENEFIT ANALYSIS
Feb 25, 2026, 14:40 PM -
PERVERSE INCENTIVES IN NUTRITION PROGRAMMING: EFFECTS OF CASH-BASED DISCHARGE SUPPORT ON CHILD HEALTH OUTCOMES IN NORTHWEST NIGERIA
Feb 25, 2026, 14:40 PM -
ECONOMIC OUTCOMES OF PHARMACOTHERAPEUTIC MANAGEMENT IN ONCOLOGY PATIENTS
Feb 25, 2026, 14:40 PM
